424 related articles for article (PubMed ID: 11377918)
1. Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve.
Sora I; Elmer G; Funada M; Pieper J; Li XF; Hall FS; Uhl GR
Neuropsychopharmacology; 2001 Jul; 25(1):41-54. PubMed ID: 11377918
[TBL] [Abstract][Full Text] [Related]
2. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.
David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P
Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918
[TBL] [Abstract][Full Text] [Related]
3. Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice.
Rünkorg K; Veraksits A; Kurrikoff K; Luuk H; Raud S; Abramov U; Matsui T; Bourin M; Kõks S; Vasar E
Behav Brain Res; 2003 Sep; 144(1-2):125-35. PubMed ID: 12946603
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
[TBL] [Abstract][Full Text] [Related]
5. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
6. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
[TBL] [Abstract][Full Text] [Related]
7. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
[TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
9. Morphine tolerance and dependence in the nociceptin receptor knockout mice.
Mamiya T; Noda Y; Ren X; Nagai T; Takeshima H; Ukai M; Nabeshima T
J Neural Transm (Vienna); 2001; 108(12):1349-61. PubMed ID: 11810400
[TBL] [Abstract][Full Text] [Related]
10. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
11. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.
Matthes HW; Maldonado R; Simonin F; Valverde O; Slowe S; Kitchen I; Befort K; Dierich A; Le Meur M; Dollé P; Tzavara E; Hanoune J; Roques BP; Kieffer BL
Nature; 1996 Oct; 383(6603):819-23. PubMed ID: 8893006
[TBL] [Abstract][Full Text] [Related]
12. Mu opioid receptor-dependent and independent components in effects of tramadol.
Ide S; Minami M; Ishihara K; Uhl GR; Sora I; Ikeda K
Neuropharmacology; 2006 Sep; 51(3):651-8. PubMed ID: 16793069
[TBL] [Abstract][Full Text] [Related]
13. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC
Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618
[TBL] [Abstract][Full Text] [Related]
14. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
Bilbao A; Cippitelli A; Martín AB; Granado N; Ortiz O; Bezard E; Chen JF; Navarro M; Rodríguez de Fonseca F; Moratalla R
Psychopharmacology (Berl); 2006 Apr; 185(2):160-8. PubMed ID: 16470403
[TBL] [Abstract][Full Text] [Related]
15. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
Alcaraz C; Vargas ML; Milanés MV
Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
[TBL] [Abstract][Full Text] [Related]
16. mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion.
Hall FS; Goeb M; Li XF; Sora I; Uhl GR
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):123-30. PubMed ID: 14969743
[TBL] [Abstract][Full Text] [Related]
17. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.
Madhavan A; He L; Stuber GD; Bonci A; Whistler JL
J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187
[TBL] [Abstract][Full Text] [Related]
18. Congenic C57BL/6 mu opiate receptor (MOR) knockout mice: baseline and opiate effects.
Hall FS; Li XF; Goeb M; Roff S; Hoggatt H; Sora I; Uhl GR
Genes Brain Behav; 2003 Apr; 2(2):114-21. PubMed ID: 12884968
[TBL] [Abstract][Full Text] [Related]
19. Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice.
Walters CL; Godfrey M; Li X; Blendy JA
Brain Res; 2005 Jan; 1032(1-2):193-9. PubMed ID: 15680959
[TBL] [Abstract][Full Text] [Related]
20. Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice.
Shoblock JR; Maidment NT
Neuropsychopharmacology; 2006 Jan; 31(1):171-7. PubMed ID: 15956992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
